AstraZeneca says FDA approves drug for rare kidney disease in adults
AstraZeneca says FDA approves drug for rare kidney disease in adults Reuters
Finance, IT & News
AstraZeneca says FDA approves drug for rare kidney disease in adults Reuters
FDA Approves Hibsago to Treat Patients With Certain Chronic HBV Without Cirrhosis Medscape
International Study Helps Support FDA Approval of HIV Drug for Newborns | Newswise Newswise
FDA Clears Fresenius multiFiltratePRO for Regional Citrate Anticoagulation The Clinical Trial Vanguard
KACH collaboration garners FDA approval of TBI diagnosis device; device recognized by TIME Army.mil